Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Melanoma

Free Subscription Articles published in Eur J Dermatol Retrieve available abstracts of 30 articles: HTML format

Single Articles

February 2025
1. RUSSO R, Turrisi R, Spagnolo F, Rossi G, et al
   Artificial intelligence for evaluation of melanoma thickness: too early to tell?
   Eur J Dermatol. 2025;35:63-64.
   PubMed    
   
   
   
2. DE MATOS PR, Rosa G, Granja B, Costa R, et al
   Amelanotic malignant melanoma arising in an area of palmoplantar keratoderma (mal de Meleda).
   Eur J Dermatol. 2025;35:52-53.
   PubMed    
   
   
   
3. SAKAGUCHI Y, Komori T, Usui S, Otsuka A, et al
   Effectiveness of combined immune checkpoint inhibitors and radiotherapy on malignant melanoma arising in chronic stasis ulcers with ulcerative in-transit metastases.
   Eur J Dermatol. 2025;35:50-52.
   PubMed    
   
   
   
4. TRUONG TT, Lapassat M, Belbezier A, Leccia MT, et al
   Home anti-PD1 immunotherapy for melanoma: results of a patient and nursing satisfaction survey.
   Eur J Dermatol. 2025;35:31-37.
   PubMed     Abstract available
   
   
   December 2024
5. LLAMAS-SEGURA C, Cebolla-Verdugo M, Vega-Castillo JJ, Ruiz-Villaverde R, et al
   Lurking non-melanoma skin cancers in patients on long-term ruxolitinib treatment.
   Eur J Dermatol. 2024;34:679-681.
   PubMed    
   
   
   
6. MECHOW N, Peitsch WK, Diehl K, Ohletz J, et al
   Adjuvant treatment decisions of patients with stage IIB/C and III melanoma in routine clinical practice.
   Eur J Dermatol. 2024;34:651-661.
   PubMed     Abstract available
   
   
   October 2024
7. SUGIYAMA T, Fukuchi K, Kitauchi Y, Shimauchi T, et al
   A case of BRAF inhibitor-induced pancreatitis in a patient with malignant melanoma.
   Eur J Dermatol. 2024;34:563-564.
   PubMed    
   
   
   
8. KAMBAYASHI Y, Fujimura T, Takahashi T, Hashimoto A, et al
   Disseminated bone marrow carcinomatosis of malignant melanoma: a case report and review of the literature.
   Eur J Dermatol. 2024;34:561-562.
   PubMed    
   
   
   
9. DRADI GG, Villegas RG, Murzubal MUF, Moraleda FP, et al
   Parallel pigmented network in lentigo maligna: a case series and correlation with in vivo reflectance confocal microscopy.
   Eur J Dermatol. 2024;34:490-496.
   PubMed     Abstract available
   
   
   August 2024
10. CAYUELA L, Pereyra-Rodriguez JJ, Hernandez-Rodriguez JC, Sendin-Martin M, et al
    Non-melanoma skin cancer burden in Spain: a nationwide analysis of incidence trends (1990-2019).
    Eur J Dermatol. 2024;34:392-397.
    PubMed     Abstract available
    
    
    June 2024
11. YOON S, Lee SY, Lee GJ, Kim JS, et al
    Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study.
    Eur J Dermatol. 2024;34:314-317.
    PubMed    
    
    
    April 2024
12. PARK YJ, Baek DJ, Kim DC, Kim YC, et al
    A case of pigmented Bartholin cyst mimicking mucosal melanoma.
    Eur J Dermatol. 2024;34:205-207.
    PubMed    
    
    
    
13. RAVNI E, Skowron F, David C, Cortez CD, et al
    Correlation between super-high magnification (400x) dermoscopy and reflectance confocal microscopy for the diagnosis of melanosis and other pigmented genital lesions.
    Eur J Dermatol. 2024;34:131-138.
    PubMed     Abstract available
    
    
    December 2023
14. SONG T, Tan C, Liu Y, Xue YN, et al
    Dermoscopic and reflectance confocal microscopy features of Netherton syndrome.
    Eur J Dermatol. 2023;33:696-697.
    PubMed    
    
    
    
15. LANGBOUR C, Law-Wan J, Ben-Saad R, Zaragoza J, et al
    Intramedullary spinal cord metastasis: a rare complication of malignant melanoma.
    Eur J Dermatol. 2023;33:694-696.
    PubMed    
    
    
    October 2023
16. FUKUCHI K, Shimauchi T, Fujiyama T, Ito T, et al
    A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment.
    Eur J Dermatol. 2023;33:550-551.
    PubMed    
    
    
    
17. KIM PJ, Lansang RP, Ko E, Abu-Hilal M, et al
    Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
    Eur J Dermatol. 2023;33:506-513.
    PubMed     Abstract available
    
    
    
18. VAN DIEREN L, Amar JZ, Geurs N, Quisenaerts T, et al
    Unveiling the power of convolutional neural networks in melanoma diagnosis.
    Eur J Dermatol. 2023;33:495-505.
    PubMed     Abstract available
    
    
    June 2023
19. SAMELA T, Fania L, Sampogna F, Mastroeni S, et al
    Incidence of keratinocyte carcinomas in Italy: an exercise in indirect estimation based on melanoma data.
    Eur J Dermatol. 2023;33:230-234.
    PubMed     Abstract available
    
    
    
20. IBRAHIM N, Ali SR, Dobbs TD, Gibson AGJ, et al
    The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.
    Eur J Dermatol. 2023;33:218-229.
    PubMed     Abstract available
    
    
    April 2023
21. GARCIA-PIQUERAS P, Aviles-Izquierdo JA
    Clues in Dermoscopy. Epidermotropic cutaneous malignant melanoma metastases: a description of 25 cases.
    Eur J Dermatol. 2023;33:190-192.
    PubMed    
    
    
    
22. PIROTH M, Goronflot T, Samaran R, Varey E, et al
    Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy.
    Eur J Dermatol. 2023;33:126-136.
    PubMed     Abstract available
    
    
    
23. BELLINATO F, Moar A, Rosina P, Gisondi P, et al
    Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma.
    Eur J Dermatol. 2023;33:121-125.
    PubMed     Abstract available
    
    
    
24. CHARPENTIER C, Riche VP, Nguyen JM, Guile R, et al
    Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
    Eur J Dermatol. 2023;33:81-86.
    PubMed     Abstract available
    
    
    
25. FRENARD C, Blanchet K, Lecerf P, Varey E, et al
    Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
    Eur J Dermatol. 2023;33:75-80.
    PubMed     Abstract available
    
    
    November 2022
26. ECKARDT J, Behrens V, Kofler K, Forchhammer S, et al
    The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence.
    Eur J Dermatol. 2022;32:750-755.
    PubMed     Abstract available
    
    
    
27. ZOUTENDIJK J, Siem D, Argenziano G, Forsea AM, et al
    The daily use of dermoscopy in the Netherlands.
    Eur J Dermatol. 2022;32:736-742.
    PubMed     Abstract available
    
    
    
28. L'ORPHELIN JM, Le Naour S, Dalle S, Varey E, et al
    Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
    Eur J Dermatol. 2022;32:691-697.
    PubMed     Abstract available
    
    
    
29. RICCI F, Fania L, Antonelli F, Ricci F, et al
    Melanoma on tattoos: a case study and review of the literature.
    Eur J Dermatol. 2022;32:703-708.
    PubMed     Abstract available
    
    
    
30. PAPANIKOLAOU ES, Sampogna F, Fania L, Di Lella G, et al
    Quality of life in caregivers of melanoma patients.
    Eur J Dermatol. 2022;32:698-702.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.